Deborah Ascheim

Deborah D. Ascheim, M.D. serves as Chief Medical Officer at Rejuvenate Bio since January 2023 and has been President of d2a Ltd. since October 2018, providing independent consulting on clinical and business development across various therapeutic areas, including gene and cell therapies. Additionally, Deborah is the Vice Chair of the Board of Directors for Physicians for Human Rights, where responsibilities have included chairing key committees and serving on the executive committee. Previous roles include Chief Medical Officer at StrideBio, Inc. and Capricor Therapeutics, Inc., and Professor of Medicine (Cardiology) at Cedars-Sinai Medical Center. Deborah's academic background includes positions at Icahn School of Medicine at Mount Sinai and Columbia University Medical Center, and educational qualifications feature a Doctor of Medicine from New York Medicine Jobs and a Bachelor of Arts in English Literature from Wellesley College.